IL305661A - Methods of administration of polypeptides of growth hormones that have effects over time - Google Patents

Methods of administration of polypeptides of growth hormones that have effects over time

Info

Publication number
IL305661A
IL305661A IL305661A IL30566123A IL305661A IL 305661 A IL305661 A IL 305661A IL 305661 A IL305661 A IL 305661A IL 30566123 A IL30566123 A IL 30566123A IL 305661 A IL305661 A IL 305661A
Authority
IL
Israel
Prior art keywords
subject
long
rhgh
dose level
week
Prior art date
Application number
IL305661A
Other languages
English (en)
Hebrew (he)
Original Assignee
Pfizer
Opko Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Opko Biologics Ltd filed Critical Pfizer
Publication of IL305661A publication Critical patent/IL305661A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL305661A 2021-03-19 2022-03-17 Methods of administration of polypeptides of growth hormones that have effects over time IL305661A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163163504P 2021-03-19 2021-03-19
US202163272417P 2021-10-27 2021-10-27
PCT/US2022/020804 WO2022197961A1 (en) 2021-03-19 2022-03-17 Methods of administering long-acting growth hormone polypeptides

Publications (1)

Publication Number Publication Date
IL305661A true IL305661A (en) 2023-11-01

Family

ID=83320806

Family Applications (1)

Application Number Title Priority Date Filing Date
IL305661A IL305661A (en) 2021-03-19 2022-03-17 Methods of administration of polypeptides of growth hormones that have effects over time

Country Status (10)

Country Link
US (1) US20240166710A1 (cg-RX-API-DMAC7.html)
EP (1) EP4308151A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022145646A (cg-RX-API-DMAC7.html)
KR (1) KR20230171936A (cg-RX-API-DMAC7.html)
AU (1) AU2022238386A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023018980A2 (cg-RX-API-DMAC7.html)
CA (1) CA3214273A1 (cg-RX-API-DMAC7.html)
IL (1) IL305661A (cg-RX-API-DMAC7.html)
MX (1) MX2023010997A (cg-RX-API-DMAC7.html)
WO (1) WO2022197961A1 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020155990A1 (en) * 2001-04-20 2002-10-24 Renasci, Inc., D/B/A Renasci Anti-Aging Center Method of optimizing growth hormone replacement
WO2009102734A1 (en) * 2008-02-11 2009-08-20 Depomed Inc. Methods for treating vasomotor symptoms using gaba analogs in a gastric retentive dosage form
US20150158926A1 (en) * 2013-10-21 2015-06-11 Opko Biologics, Ltd. Long-acting polypeptides and methods of producing and administering same
HUE050002T2 (hu) * 2013-10-21 2020-11-30 Opko Biologics Ltd Hosszan ható polipeptidek és eljárás azok elõállítására és beadására
EP4732848A3 (en) * 2014-11-21 2026-07-29 Ascendis Pharma Endocrinology Division A/S Long-acting growth hormone dosage forms
KR102527180B1 (ko) * 2014-12-10 2023-04-27 옵코 바이오로직스 리미티드 장기간 작용성 ctp-변형된 성장 호르몬 폴리펩타이드의 제조 방법
MY184625A (en) * 2014-12-10 2021-04-09 Opko Biologics Ltd Methods of producing long acting ctp-modified growth hormone polypeptides

Also Published As

Publication number Publication date
BR112023018980A2 (pt) 2023-12-05
EP4308151A4 (en) 2025-02-26
EP4308151A1 (en) 2024-01-24
WO2022197961A1 (en) 2022-09-22
CA3214273A1 (en) 2022-09-22
KR20230171936A (ko) 2023-12-21
US20240166710A1 (en) 2024-05-23
JP2022145646A (ja) 2022-10-04
MX2023010997A (es) 2023-11-28
AU2022238386A1 (en) 2023-09-14

Similar Documents

Publication Publication Date Title
US12029780B2 (en) Long-acting polypeptides and methods of producing and administering same
Gharib et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children—2003 update
Reh et al. Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review
Smith et al. A growth differentiation factor 15 receptor agonist in randomized placebo-controlled trials in healthy or obese persons
US20140162954A1 (en) Fusion of human growth hormone and albumin formulation and uses thereof
JP2016535080A (ja) 療法における使用のためのインスリン様成長因子模倣物
TWI777407B (zh) 長效型多肽及其生產和給藥的方法
Kemp Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options
US20240166710A1 (en) Methods of administering long-acting growth hormone polypeptides
CN117425490A (zh) 施用长效生长激素多肽的方法
Yuen et al. Long-acting growth hormone preparations
HK40098775A (en) Methods of administering long-acting growth hormone polypeptides
Dao et al. Human growth hormone
US20070066519A1 (en) Use of human growth hormone in multiple system atrophy
Wang et al. Tesamorelin, a human growth hormone releasing factor analogue
Dao et al. Human growth hormone
US20250325560A1 (en) Methods for improving muscle mass, strength, or function with a combination of testosterone and growth hormone
Luz et al. History and Current Status of Growth Hormone Treatment in Children: CC Luz, PF Collett-Solberg
Steelman et al. Cara, CL Roland, CT Taylor, SR Valluri, and MP Wajnrajch are employees
US20200000884A1 (en) Treatment of adult growth hormone deficiency with human growth hormone analogues
Ying et al. Once-Weekly Lonapegsomatropin Was Efficacious and Well Tolerated in Chinese Children with Growth Hormone Deficiency: Results from a Phase 3 Randomized Trial
Class et al. Patent application title: FUSION OF HUMAN GROWTH HORMONE AND ALBUMIN FORMULATION AND USES THEREOF Inventors: Kurt Brown (Narbeth, PA, US) Merav Bassan (Netanya, IL) Assignees: Teva Pharmaceutical Industries Ltd.
Ribeiro Somatrogon. Long-acting human growth hormone, Treatment of human growth hormone deficiency
HK40034109A (en) Long-acting polypeptides and methods of producing and administering same
Kochar Recent Trends in Use of Growth Hormone Therapy